Glenmark generics unit launches azathioprine in US
MUMBAI (Reuters) - Drugmaker Glenmark Pharmaceuticals Ltd said on Thursday its generics unit has launched azathioprine tablets in the United States.
Glenmark Generics Ltd acquired full marketing rights for the drug from an unnamed company, the company said in a statement.
Azathioprine is a generic version of Imuran, used to prevent rejection in kidney transplantation. It is also used to treat rheumatoid arthritis, Glenmark said in a statement.
Imuran had sales of about $36 million for the 12 months to June 2008, the company added.
© Thomson Reuters 2009 All rights reserved
Dubai Debt Fears
Banks outside the Gulf played down their exposure to Dubai debt, after fears the emirate could default and even derail world economic recovery prompted a sell-off in global markets. Full Article | Slideshow
India Investment Summit 2009
Top executives and bankers discuss their own plans and the broader opportunities and challenges for India. Full Coverage
India
US
UK
